HSM vs. TON, NTBR, LIFS, SFE, TPK, FAN, GEN, TYMN, JHD, and COD
Should you be buying Samuel Heath & Sons stock or one of its competitors? The main competitors of Samuel Heath & Sons include Titon (TON), Northern Bear (NTBR), LifeSafe (LIFS), Safestyle UK (SFE), Travis Perkins (TPK), Volution Group (FAN), Genuit Group (GEN), Tyman (TYMN), James Halstead (JHD), and Compagnie de Saint-Gobain (COD). These companies are all part of the "building products & equipment" industry.
Samuel Heath & Sons vs.
Titon (LON:TON) and Samuel Heath & Sons (LON:HSM) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking.
In the previous week, Samuel Heath & Sons had 1 more articles in the media than Titon. MarketBeat recorded 1 mentions for Samuel Heath & Sons and 0 mentions for Titon. Titon's average media sentiment score of 0.00 beat Samuel Heath & Sons' score of -2.00 indicating that Titon is being referred to more favorably in the media.
Samuel Heath & Sons has a net margin of 5.04% compared to Titon's net margin of -5.06%. Samuel Heath & Sons' return on equity of 6.57% beat Titon's return on equity.
Titon received 28 more outperform votes than Samuel Heath & Sons when rated by MarketBeat users. However, 65.91% of users gave Samuel Heath & Sons an outperform vote while only 60.53% of users gave Titon an outperform vote.
Titon has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Samuel Heath & Sons has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500.
28.3% of Titon shares are owned by institutional investors. 63.7% of Titon shares are owned by company insiders. Comparatively, 93.5% of Samuel Heath & Sons shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Samuel Heath & Sons has lower revenue, but higher earnings than Titon. Titon is trading at a lower price-to-earnings ratio than Samuel Heath & Sons, indicating that it is currently the more affordable of the two stocks.
Titon pays an annual dividend of GBX 1 per share and has a dividend yield of 1.3%. Samuel Heath & Sons pays an annual dividend of GBX 13 per share. Titon pays out -11.5% of its earnings in the form of a dividend. Samuel Heath & Sons pays out 4,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Titon is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Samuel Heath & Sons beats Titon on 9 of the 16 factors compared between the two stocks.
Get Samuel Heath & Sons News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Samuel Heath & Sons Competitors List
Related Companies and Tools
This page (LON:HSM) was last updated on 2/22/2025 by MarketBeat.com Staff